Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target ...

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 ... FDA had been on track to grant Novavax full approval – without restrictions — by ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

Novavax makes the nation’s only traditional protein-based coronavirus ... The FDA had been on track to grant Novavax full approval – without restrictions — by its April 1 target date ...

FDA Approves Novavax COVID-19 Shot but ... showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without ...